Real-time enrollment status for this ovarian cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 3:02 PM UTC
| NCT Number | NCT06843447 |
| Recruiting Status | Recruiting |
| Condition | Ovarian Cancer |
| Phase | PHASE1 |
| Target Enrollment | 460 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Merck Sharp & Dohme LLC |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 28, 2026: Clinical trial NCT06843447 is currently recruiting participants. This phase1 study for ovarian cancer is actively seeking new participants at 10 locations across the United States. The study is sponsored by Merck Sharp & Dohme LLC. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06843447 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06843447 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.